Trial Profile
A Multi-Center, Double-Blind, Pilot Study of Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Creatine monohydrate (Primary) ; Minocycline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms NET-PD
- 07 Oct 2009 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 04 Aug 2008 New trial record.